Benzoic Acid

Benzoic Acid

SCHEMBL7141174

COc1cccc(OC(=O)Nc2ccc3[nH]c(C)c(CCN(C)Cc4cc(N(C)C)cnn4)c3c2)c1.O=C(O)c1ccccc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDPP4HTR1BHTR1D

The experimentally established mechanism targets of Benzoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1D known ✓ P28221 1/20 0.38
HTR1F P30939 1/20 0.41
LMNA P02545 9/20 0.39
MAPT P10636 11/20 0.39
KMT2A Q03164 10/20 0.39
MEN1 O00255 9/20 0.39
ALDH1A1 P00352 5/20 0.39
HTT P42858 4/20 0.39
SMN1; SMN2 Q16637 5/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALOX12 P18054 2/20 0.38
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
HTR1E P28566 1/20 0.38
HTR7 P34969 1/20 0.38
HTR5A P47898 1/20 0.38
HTR6 P50406 1/20 0.38
HPGD P15428 1/20 0.38
KDM4E B2RXH2 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzoic Acid SCHEMBL8549411 0.86 ACHE (0.37) LMNAMAPTKMT2AMEN1ALDH1A1
Benzoic Acid SCHEMBL8691851 0.86 BCHE (0.37) LMNAMAPTKMT2AMEN1ALDH1A1
Benzoic Acid SCHEMBL8191205 0.84 HTR1F (0.45) HTR1FLMNAMAPTKMT2AMEN1
Benzoic Acid SCHEMBL7141730 0.76 HTR1F (0.34) HTR1FMAPTKMT2AMEN1ALDH1A1
Benzoic Acid SCHEMBL7142175 0.75 MAPT (0.34) HTR1FLMNAMAPTKMT2AMEN1
Benzoic Acid SCHEMBL8549272 0.70 NPC1 (0.35) MAPTKMT2AMEN1ALDH1A1SMN1; SMN2
Benzoic Acid SCHEMBL8548987 0.70 NPC1 (0.35) LMNAMAPTKMT2AMEN1ALDH1A1
Benzoic Acid SCHEMBL8435537 0.68 PDPK1 (0.33) LMNAMAPT
Benzoic Acid SCHEMBL8436196 0.67 PDPK1 (0.33)
SCHEMBL7138192 0.66 HTR1F (0.80) HTR1FMAPTKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
EP-0994109-A2 1-(3-(1-Pyrrolidinyl)propyl)-3-ethylcarbodiimide and a solid phase coupling agent ELI LILLY AND COMPANY (US) 2000-04-19 EP disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
WO-1997013512-A1 N-[2-SUBSTITUTED-3-(2-AMINOETHYL)-1H-INDOL-5-YL]-AMIDES: NEW 5-HT1F AGONISTS ELI LILLY AND COMPANY (US) 1997-04-17 WO disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed